Both in Biotechnology
Vor Biopharma vs Novavax
Over the past year VOR returned −11.4% and NVAX returned +22.4%; their daily moves had a correlation of 0.17.
VOR −11.4% NVAX +22.4%Growth of $1, one year, split-adjusted
| Metric | VOR | NVAX |
|---|---|---|
| Price | $19.86 | $9.68 |
| Market cap | $1.22B | $1.60B |
| Today | +3.17% | +1.57% |
| 1 month | +6.9% | −22.9% |
| 6 months | +28.0% | +19.5% |
| Year to date | +51.8% | +44.0% |
| 1 year | −17.6% | +15.2% |
| Revenue growth (YoY) | — | −76.3% |
| Gross margin | — | 74.9% |
| Net margin | — | −94.2% |
| P/E (TTM) | 0.9× | — |
| Price / sales | — | 3.9× |
| Net cash | $481.6M | $422.0M |
| Dividend yield | — | — |
| Volatility (60d) | 59.2% | 80.6% |
| Short % of float | 17.6% | 30.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).